THURSDAY, May 17, 2018 (HealthDay News) -- The U.S. Food and Drug Administration on Wednesday approved the non-opioid drug Lucemyra(lofexidine) to help adults cope with symptoms of opioid withdrawal
I think this is another Hype by the Pharmaceutical company to gouge the poor patient with Opioid addiction problems .
it has not been shown to be any more superior than Clonidine or tizanidine.both of which are much cheaper than this new FDA approved drug.
I think this is another Hype by the Pharmaceutical company to gouge the poor patient with Opioid addiction problems .
it has not been shown to be any more superior than Clonidine or tizanidine.both of which are much cheaper than this new FDA approved drug.
No comments:
Post a Comment